MCB Insiders Send Mixed Signals as Q3 Print Arrives

Metropolitan Bank Holding Corp. reports Q3 earnings today against a backdrop where insiders and options traders are pulling in different directions.

The insider picture is the more striking of the two. Net selling of roughly $1.24 million over the past 90 days tells a cautious story at first glance, but the composition matters. Director Robert Patent sold 25,000 shares across three trades between June and August, accounting for the bulk of the net outflow, while CFO Daniel Dougherty made an open-market purchase of 1,000 shares at $89.98 in late July, right after the prior quarter's print. None of the selling by Patent was conducted under a pre-arranged 10b5-1 plan, which makes it discretionary, though director-level selling carries less weight as a signal than executive action. The CFO's buy, modest as it is, points the other way.

Options positioning has moderated slightly since the article published yesterday, though it remains tilted toward caution. The put/call ratio has eased from the 52-week high of 1.85 touched last Friday to 1.35, still well above the 20-day average of 1.12. The stock has recovered ground since then too, gaining 2.7% on Tuesday to close at $88.87, reversing much of the prior month's drift. Close peers BWB, FFBC and UCB all slipped on Tuesday, making MCB's bounce the more notable move into the print. Borrow availability remains extremely loose, with shares available to borrow running at more than 23 times the current short interest level, so the 6.4% short position in the float carries no squeeze risk.

The analyst debate is essentially a valuation one. Keefe, Bruyette & Woods holds an Outperform rating with a $110 target, while UBS sits at Neutral with a $100 target. Both firms trimmed targets in late July following the Q2 print, which the stock fell more than 8% on in a single session. The consensus mean sits around $105, roughly 18% above the current price, but the PE of just over 8 times and a price-to-book below 1 suggest the bulls are looking at a bank trading at a discount to tangible book rather than one priced for growth. FDIC call report data shows net loans and leases have risen for nine consecutive quarters and total assets for six, both streaks intact through April 2026, a consistent expansion of the balance sheet that supports the bull case on growth momentum.

The Q3 print will test whether Metropolitan Bank can recover credibility after July's sharp post-earnings selloff, and whether the valuation discount to peers is justified or represents an entry point ahead of further balance sheet growth.